IART
Integra LifeSciences Holdings Corporation Healthcare - Medical Devices Investor Relations →
Integra LifeSciences Holdings Corporation (IART) closed at $8.94 as of 2026-03-20, trading 72.7% below its 200-week moving average of $32.77. This places IART in the extreme value zone. The stock is currently moving closer to the line, down from -72.0% last week. With a 14-week RSI of 27, IART is in oversold territory.
Trading volume is running at 1.7x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.89 ratio) is neutral — neither side is clearly dominating.
Over the past 1548 weeks of data, IART has crossed below its 200-week moving average 12 times. On average, these episodes lasted 48 weeks. Historically, investors who bought IART at the start of these episodes saw an average one-year return of +34.0%.
With a market cap of $697 million, IART is a small-cap stock. The company generates a free cash flow yield of 6.4%, which is healthy. Return on equity stands at -39.9%. The stock trades at 0.7x book value.
The company has been aggressively buying back shares, reducing its share count by 6.9% over the past three years. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 29.8 years, a hypothetical investment of $100 in IART would have grown to $198, compared to $1692 for the S&P 500. IART has returned 2.3% annualized vs 10.0% for the index, underperforming the broader market over this period.
Free cash flow has been declining at a -100% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: IART vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After IART Crosses Below the Line?
Across 12 historical episodes, buying IART when it crossed below its 200-week moving average produced an average return of +35.4% after 12 months (median +24.0%), compared to +25.8% for the S&P 500 over the same periods. 75% of those episodes were profitable after one year. After 24 months, the average return was +36.2% vs +39.6% for the index.
Each line shows $100 invested at the moment IART crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
IART has crossed below its 200-week MA 12 times with an average 1-year return of +34.0% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jul 1996 | Feb 2000 | 185 | 71.6% | -48.4% | +27.6% |
| May 2000 | May 2000 | 1 | 7.4% | +141.7% | +180.0% |
| Oct 2002 | Nov 2002 | 3 | 4.4% | +113.8% | +40.3% |
| Oct 2008 | Feb 2010 | 71 | 49.4% | -0.7% | -39.7% |
| May 2010 | Sep 2010 | 17 | 12.6% | +24.0% | -48.4% |
| Aug 2011 | Jul 2012 | 47 | 35.9% | +6.8% | -46.0% |
| Oct 2012 | Oct 2012 | 1 | 0.0% | +17.4% | -46.6% |
| Nov 2012 | Nov 2012 | 1 | 1.3% | +23.1% | -46.0% |
| Apr 2013 | Aug 2013 | 19 | 15.8% | +18.5% | -48.2% |
| Mar 2020 | May 2020 | 12 | 26.8% | +32.6% | -82.1% |
| Jun 2020 | Nov 2020 | 22 | 17.5% | +45.6% | -81.5% |
| Jun 2022 | Ongoing | 197+ | 73.5% | Ongoing | -83.6% |
| Average | 48 | — | +34.0% | — |
Frequently Asked Questions
Is IART below its 200-week moving average?
Yes. As of 2026-03-20, Integra LifeSciences Holdings Corporation (IART) is trading 72.7% below its 200-week moving average of $32.77. The current price is $8.94.
What is IART's 200-week moving average price?
Integra LifeSciences Holdings Corporation's 200-week moving average is $32.77 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when IART drops below its 200-week moving average?
IART has crossed below its 200-week moving average 12 times in our data. On average, buying at that moment produced a one-year return of +34.0%. These dips have historically been decent entry points. These episodes lasted 48 weeks on average.
Is IART a good value right now?
Here's what our data says about IART as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 27 (oversold). Free cash flow yield is 6.4%. Return on equity is -39.9%. Price-to-book is 0.7x. This is not a buy or sell recommendation — always do your own research.
How does IART compare to the S&P 500?
Over the past 29.8 years, $100 invested in IART would have grown to $198, compared to $1692 for the S&P 500. That's 2.3% annualized vs 10.0% for the index. IART has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20